ask="1.58"
ask_size="6000"
average_daily_volume="82048"
bid="0.98"
bid_size="200"
book_value="0.39"
change="+0.01"
change_from_200_day_moving_average="-0.00"
change_from_50_day_moving_average="-0.14"
change_from_52_week_high="-0.47"
change_From_52_week_low="0.80"
change_in_percent="+0.67%"
close="1.51"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-0.25"
ebitda="-12.06M"
eps_estimate_current_year="-0.14"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.08"
ex_dividend_date="6/24/2005"
float_shares="35315000"
high="1.87"
high_52_weeks="1.98"
last_trade_date="1/17/2017"
last_trade_price="1.51"
last_trade_size="224"
last_trade_time="4:00pm"
low="1.46"
low_52_weeks="0.71"
market_capitalization="102.02M"
moving_average_200_day="1.51"
moving_average_50_day="1.65"
name="Biolase
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.51"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-0.15%"
percent_change_from_50_day_moving_average="-8.47%"
percent_change_from_52_week_high="-23.74%"
percent_change_from_52_week_low="+112.68%"
previous_close="1.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.89"
price_per_sales="1.93"
revenue="52.44M"
shares_outstanding="67565000"
short_ratio="26.20"
stock_exchange="NCM"
symbol="BIOL"
volume="955560"
weeks_range_52="0.71 - 1.98"
